Potential Risks And Benefits Of Gainoffunction Research Summary Of A Workshop 1st Edition National Research Council Annemarie Mazza Institute Of Medicine Board On Health Sciences Policy Policy And Global Affairs And Law Technology Committee On Science Division On Earth And Life Studies Board On Life Sciences India Hookbarnard Audrey by National Research Council; Anne-marie Mazza; Institute Of Medicine; Board On Health Sciences Policy; Policy And Global Affairs; And Law Technology Committee On Science; Division On Earth And Life Studies; Board On Life Sciences; India Hook-barnard; Audrey 9780309367844, 0309367840 instant download after payment.

On October 17, 2014, spurred by incidents at U.S. government laboratories that raised serious biosafety concerns, the United States government launched a one-year deliberative process to address the continuing controversy surrounding so-called "gain-of-function" (GOF) research on respiratory pathogens with pandemic potential. The gain of function controversy began in late 2011 with the question of whether to publish the results of two experiments involving H5N1 avian influenza and continued to focus on certain research with highly pathogenic avian influenza over the next three years. The heart of the U.S. process is an evaluation of the potential risks and benefits of certain types of GOF experiments with influenza, SARS, and MERS viruses that would inform the development and adoption of a new U.S. Government policy governing the funding and conduct of GOF research. Potential Risks and Benefits of Gain-of-Function Research is the summary of a two-day public symposia on GOF research. Convened in December 2014 by the Institute of Medicine and the National Research Council, the main focus of this event was to discuss principles important for, and key considerations in, the design of risk and benefit assessments of GOF research. Participants examined the underlying scientific and technical questions that are the source of current discussion and debate over GOF research involving pathogens with pandemic potential. This report is a record of the presentations and discussion of the meeting.